Current and Emerging NMB Therapies with J. Ross Renew, MD, FASA, FASE and Anthony L. Kovac, MD

Update: 2021-06-01

Description

In this podcast, expert clinicians will discuss the clinical data supporting the use of current and investigational neuromuscular blockade agents.

Comments

In Channel

Significance of a Multidisciplinary Approach for NMBAs with J. Ross Renew, MD, FASA, FASE and Richard Pence, CRNA, MHA

2021-06-0110:43

Current and Emerging NMB Therapies with J. Ross Renew, MD, FASA, FASE and Anthony L. Kovac, MD

2021-06-0117:21

Benefits and Drawbacks of Conventional Reversal Agents with J. Ross Renew, MD, FASA, FASE, and Richard Pence, CRNA, MHA

2021-06-0113:34

Best Practices for Monitoring Neuromuscular Blockade with J. Ross Renew, MD, FASA, FASE, and Anthony L. Kovac, MD

2021-06-0114:37

00:00

J. Ross Renew, MD, FASA, FASE